An impedance-controlled system for endometrial ablation: Five-year follow-up of 107 patients

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 52, Issue 6, 2007, Pages 467-472

  Gallinat, Adolf ^a  

^a Tagesklinik Altonaer Strasse   (Germany)

Author keywords

Dysfunctional uterine bleeding; Endometrial ablation; Menorrhagia; NovaSure

Indexed keywords

ADULT; AMENORRHEA; ARTICLE; ENDOMETRIUM ABLATION; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENORRHAGIA; METRORRHAGIA; PATIENT SAFETY; PILOT STUDY; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; ELECTRIC IMPEDANCE; ELECTROCOAGULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENORRHAGIA; METRORRHAGIA; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34250885707     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sculpher M, Bryan S, Dwyer N, Hutton J, et al: An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. Br J Obstet Gynaecol 1993;100:244-252
2. Medical Data International, Inc: Gynecological Surgery. Englewood, CO, MedPro Month, 1997
3. Côté I, Jacobs P, Cumming D: Use of health services associated with increased menstrual loss in the United States. Am J Obstet Gynecol 2003;188:343-348
4. Côté I, Jacobs P, Cumming D: Work loss associated with increased menstrual loss in the United States. Obstet Gynecol 2002;100:683-687
5. Kuppermann M, Varner R, Summitt R, et al: Effect of hysterectomy vs. medical treatment on health-related quality of life and sexual functioning. JAMA 2004;291:1447-1455
6. Neuwirth RS: Hysteroscopy and gynecology: Past, present and future. J Am Assoc Gynecol Laparosc 2001;8:93-198
7. Dicker RC, Greenspan JR, Strauss LT, et al: Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States: The collaborative review of sterilization. Am J Obstet Gynecol 1982;144:841-848
8. O'Connor H, Magos A: Endometrial resection for the treatment of menorrhagia. N Engl J Med 1996;355:151-156
9. Gallinat A: NovaSure impedance controlled system for endometrial ablation: Three-year follow-up on 107 patients. Am J Obstet Gynecol 2004;191:1585-1589
10. Gallinat A, Nugent W: NovaSure impedance-controlled system for endometrial ablation. J Am Assoc Gynecol Laparosc 2002;9:279-285
11. Kuhrt B: Klinische Erfahrungen in der Anaesthesie bei ambulanten Eingriffen. Hamburg, Germany, GlaxoWellcome GmbH, 1999, p 12
12. Higham JM, O'Brien PMS, Shaw RW: Assessment of menstrual blood loss using a pictoral chart. Br J Obstet Gynaecol 1990;97:734-739
13. Laberge PY, Sabbah R, Fortin C, et al: Assessment and comparison of intra- and postoperative pain associated with NovaSure and ThermaChoice endometrial ablation systems. J Am Assoc Gynecol Laparosc 2003;10:223-232
14. Cooper J, Gimpelson R, Laberge P, et al: A randomized, multicenter trial of safety and efficacy of the NovaSure System in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2002;9:418-428
15. Abbott J, Hawe J, Hunter D, et al: A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fertil Steril 2003;80:203-208
16. Busund B, Erno LE, Gronmark A, et al: Endometrial ablation with NovaSure GE: A pilot study. Acta Obstet Gynecol Scand 2003;82:65-68
17. Fulop T, Rakoczi I, Barna I: NovaSure Impedance Controlled Endometrial Ablation System: Long-term follow-up results. Proc of IInd World Congress on Controversies in Obstetrics, Gynecology & Infertility. Second volume. Paris, 2001, pp 149-155
18. Bongers MY, Bourdrez P, Mol BW, et al: Randomised controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. Br J Obstet Gynaecol 2004; 111:1095-1102
19. Cooper J, Brill A, Fulop T: Is endometrial pretreatment necessary in Nova Sure 3-D endometrial ablation? Gynecol Endosc 2001;10:179-183
20. Sowter MC, Lethaby A, Singla AA: Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding. Cochrane Database Syst Rev 2002;CD001124
21. Cooper J, Gimpelson R: Summary of Safety and Effectiveness Data (SSED) from FDA: A valuable source of information on the performance of global endometrial ablation devices. J Reprod Med 2004;49:267-273
22. Donnez J, Vilos G, Gannon MJ, et al: Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: A 3-year follow-up evaluation. Fertil Steril 2001;75:620-622
23. Loffer FD, Grainger D: Five-year follow-up of patients participating in a randomized trial of uterine balloon therapy versus rollerball ablation for treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2002;9:429-435
24. Goldrath MH: Evaluation of HydroThermAblator and rollerball endometrial ablation for menorrhagia 3 years after treatment. J Am Assoc Gynecol Laparosc 2003;10:505-511
25. Cooper KG, Bain C, Lawrie L, et al: A randomised comparison of microwave endometrial ablation with transcervical resection of the endometrium: Follow up at a minimum of five years. Br J Obstet Gynaecol 2005;112:470-475